SC 13G | 2007-02-12 | Prospect Venture Partners III L P | NOVAVAX INC | - | 5.0% | EDGAR |
SC 13G/A | 2007-02-06 | OPPENHEIMER FUNDS INC | NOVAVAX INC | 6,491,698 | 10.5% | EDGAR |
SC 13D | 2006-03-10 | KPCB HOLDINGS INC | NOVAVAX INC | 0 | 0.0% | EDGAR |
SC 13G | 2006-01-09 | OPPENHEIMER FUNDS INC | NOVAVAX INC | 6,028,203 | 12.3% | EDGAR |
SC 13D/A | 2005-11-04 | SJ STRATEGIC INVESTMENTS LLC | NOVAVAX INC | 0 | - | EDGAR |
SC 13D/A | 2005-10-13 | KING PHARMACEUTICALS INC | NOVAVAX INC | 0 | 0.0% | EDGAR |
SC 13D/A | 2005-09-06 | SJ STRATEGIC INVESTMENTS LLC | NOVAVAX INC | 4,001,500 | - | EDGAR |
SC 13D/A | 2004-08-26 | KING PHARMACEUTICALS INC | NOVAVAX INC | 4,100,931 | 10.4% | EDGAR |
SC 13G/A | 2004-02-18 | RS INVESTMENT MANAGEMENT CO LLC | NOVAVAX INC | - | 0.0% | EDGAR |
SC 13D | 2003-02-26 | SJ STRATEGIC INVESTMENTS LLC | NOVAVAX INC | 5,757,000 | - | EDGAR |
SC 13G | 2003-02-14 | RS INVESTMENT MANAGEMENT CO LLC | NOVAVAX INC | - | 7.2% | EDGAR |
SC 13D/A | 2002-07-24 | KING PHARMACEUTICALS INC | NOVAVAX INC | 4,748,309 | - | EDGAR |
SC 13G/A | 2002-01-25 | SAFECO CORP | NOVAVAX INC | - | 2.8% | EDGAR |
SC 13D/A | 2001-09-19 | KING PHARMACEUTICALS INC | NOVAVAX INC | 2,860,490 | - | EDGAR |
SC 13D/A | 2001-04-10 | ANACONDA OPPORTUNITY FUND L P | NOVAVAX INC | 2,080,962 | 9.4% | EDGAR |
SC 13D/A | 2001-04-09 | ANACONDA OPPORTUNITY FUND L P | NOVAVAX INC | 2,080,962 | 9.4% | EDGAR |
SC 13G | 2001-02-15 | RS INVESTMENT MANAGEMENT CO LLC | NOVAVAX INC | 975,700 | 5.0% | EDGAR |
SC 13G | 2001-01-23 | SAFECO CORP | NOVAVAX INC | - | 5.4% | EDGAR |
SC 13D | 2000-12-29 | KING PHARMACEUTICALS INC | NOVAVAX INC | 2,000,000 | - | EDGAR |
SC 13D/A | 2000-03-28 | ANACONDA OPPORTUNITY FUND L P | NOVAVAX INC | 2,353,862 | 12.4% | EDGAR |